Despite Strong 2021 Performance Headwinds Remain for Biosimilars Uptake · BioBuzz
Biosimilars uptake is increasing in the U.S. but strong market headwinds are limiting market share and impeding stronger competition and lower prices.
Source: biobuzz.io